Skip to Content

University of Colorado Boulder
Search

Search

Other ways to search:

  • Events Calendar
  • Campus Map

Main menu

  • Home
  • About
  • Academics
  • Admissions
  • Research
  • Visit

Secondary Menu

  • Students
  • Faculty
  • Staff
  • Families
  • Alumni

Search

Other ways to search:

  • Events Calendar
  • Campus Map

Mobile menu

  • Home
  • About
  • Academics
  • Admissions
  • Research
  • Visit
  • Students
  • Faculty
  • Staff
  • Families
  • Alumni
Impacting Humanity

Breadcrumb

Home Research Research Focus Areas Biosciences Impacting Humanity

Impacting Humanity

Virus infected cell graphic

Developing Treatments for Infectious Disease

Biologist Larry Gold, an internationally regarded DNA and RNA researcher, co-founded Synergen in 1981, when biotechnology was still an emerging field. In 1992, he founded NeXagen, now part of Gilead Sciences, which develops treatments for infectious disease. And in 2000, he founded SomaLogic with the goal of transforming how diseases are detected and diagnosed.

  • Professor, Molecular, Cellular, and Developmental Biology
Ryan Gill

Enabling Genetic Exploration

Ryan Gill, founder of Inscripta, has launched multiple successful technology startups. Gill was a key inventor of Inscripta's foundational technology, which enables rapid exploration of the genetic landscape at the whole genome scale, unlocking every cell’s fullest potential.

  • Co-founder, Inscripta
  • Professor, Chemical and Biological Engineering
Tin Tin Su

Fighting Cancer

Tin Tin Su’s innovative work with fruit flies led to the patenting of a compound that keeps radiation-treated cancer cells from re-growing. Her startup, SuviCa, develops cancer therapeutics that exploit a cellular mechanism critical to cancer re-growth after treatment with standard therapies.

  • Co-founder, SuviCa
  • Professor, Molecular, Cellular and Developmental Biology
Illustration of pain in a person's wrist

Helping Alleviate Chronic Pain

Linda Watkins strives to understand how to control pathological pain states. Her work has yielded 300-plus peer-reviewed publications in journals such as Nature, Science and Journal of Neuroscience. A co-founder of Xalud Therapeutics, she is a world-renowned authority on the neurological applications of glial attenuation, focusing on alleviating chronic pain.

  • John Liebeskind Pain Management Research Award (2010)
  • Distinguished Professor, Psychology and Neuroscience
  • Co-Chair, Xalud Therapeutics Scientific Advisory Board
Molecular graphic

Making Chemotherapy Safer

Marvin Caruthers co-founded Amgen in 1980 to apply his work with RNA synthesis, DNA synthesis and analogues. Today, Amgen’s therapies help prevent infections in patients undergoing chemotherapy.

  • Co-founder, Amgen Inc.
  • Distinguished Professor, Chemistry and Biochemistry

Apply for Admission

Visit Campus

Support CU Boulder

Get Help

  • Safety & Health Services
  • COVID-19 Information
  • Campus Communications
  • Emergency Alert System
  • New Student & Family Programs

Getting Around

  • Campus Map
  • Campus Events
  • Parking & Transportation
  • Visit Information

Information for

  • Faculty & Staff
  • Families
  • Journalists

Initiatives

  • Business & Industry Collaborations
  • Diversity & Community Engagement
  • Free Speech
  • Innovation & Entrepreneurship
  • International Students
  • Public & Outreach Programs
  • Sustainability

Be Boulder.

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Instagram
  • Pinterest

University of Colorado Boulder

© Regents of the University of Colorado
Contact Us • Privacy • Legal & Trademarks 
Accessibility • Student Consumer Information • Policies • CU Boulder Jobs

Download the Clery Act Annual Security & Fire safety report, or request a paper copy from the CU Boulder Police Department.  

Return to the top of the page